Skip to main content

Inspection visit

Inspection

ELDORADO REHAB & HEALTHCARECMS #1458903 citations on this visit
3 citations recorded

Inspector’s narrative

What the inspector wrote

This survey cited 3 deficiencies. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0761 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview and record review, the facility failed to accurately label insulin with resident's name and date of opening for 6 (R3, R7, R11, R14, R16, R37) of 12 residents reviewed for medication labeling and storage in a sample of 26. Findings include: On [DATE] at 10:10AM, the medication cart serving rooms 100 through 308 was observed to have 1 Novolog Flexpen with no name or open date, 2 of R14's Humalog Kwikpens with no open date, 1 Levemir Flextouch with no name or open date, 1 Humalog Kwikpen with no name or open date, 1 of R11's Basaglar pens with no date, 1 Lantus vial with no name or date, and 1 of R14's Lantus vials with no open date. V4 (Registered Nurse/RN) said all the insulins should be labeled with the resident's name and date of opening. R7's face sheet documented an admission date of [DATE] and diagnoses including: hypertension, heart failure, major depressive disorder. R7's Physician Order Sheet (POS) documented an [DATE] order for Lantus 100 unit/ ml (milliliter) 25 units every morning. R11's face sheet documented an admission date of [DATE] and diagnoses including: hypertension, anxiety disorder, cerebral infarction, fatty liver. R11's POS documented a [DATE] order for Basaglar 100 unit/ ml 35 units at bedtime, an [DATE] order for Novolog 100 unit/ ml 8 units 3 times a day before meals, and a [DATE] order for Novolog 100 unit/ ml sliding scale three times a day. R14's face sheet documented an admission date of [DATE] and diagnoses including: anxiety disorder, type 2 diabetes mellitus, hypertension. R14's POS documented a [DATE] order for Lantus 100 unit/ ml 12 units twice a day, [DATE] order for Humalog 100 unit/ ml sliding scale twice a day. R37's face sheet documented an admission date of [DATE] and diagnoses including: anemia in chronic kidney disease, end stage renal failure, type 2 diabetes mellitus, hypertension. R37's POS documented a [DATE] order for Humalog 100 unit/ ml 3 units with meals three times daily, and a [DATE] order for Humalog 100 unit/ ml sliding scale twice a day. On [DATE] at 1:38PM, V2 (Director of Nursing/DON) said R7, R11, R14, and R37 were the only residents served from the 100 through 308 medication cart with orders for the types of undated insulins found. (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 145890 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 145890 B. Wing A. Building (X3) DATE SURVEY COMPLETED 01/06/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Eldorado Rehab & Healthcare 1001 A Jefferson Street Eldorado, IL 62930 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some On [DATE] at 9:56AM, the medication cart serving rooms 400 through 504 was observed to have 2 Basaglar pens with no name or open date, 2 Novolog Flexpens with no name or open date, 2 Levemir Flextouch with no name or open date, 1 Humalog Kwikpen with R16's name written on it but no opened date. V5 (Licensed Practical Nurse/LPN) said he was unsure who the different insulins belonged to because he mostly worked dayshift and those different type of insulins were given on a different shift. V5 said the resident's name and date of opening should be written on them. R3's face sheet documented an admission date of [DATE] and diagnoses including: chronic diastolic heart failure, type 2 diabetes mellitus, anemia in chronic kidney disease. R3's POS documented a [DATE] order for Levemir 100 unit/ ml 20 units every morning, and a [DATE] order for Levemir 100 units/ ml 10 units every night. R16's face sheet documented an admission date of [DATE] and diagnoses including: heart failure, anxiety disorder, major depressive disorder, obstructive sleep apnea. R16's POS documented a [DATE] order for Basaglar 100 unit/ ml 40 units twice a day, a [DATE] Humalog 100 unit/ ml sliding scale twice a day. On [DATE] at 1:38PM, V2 (DON) said R3 and R16 were the only residents served from the 400 through 504 medication cart with orders for the types of undated insulins found. V2 said all insulin pens and vials should have the resident's name and date of opening on them. V2 said once insulin pens and vials are opened, they have an expiration date depending on the type of insulin some being 28 days and some being 31 days. V2 said if there was no open date on the insulin, staff would not know when the insulin becomes expired. V2 said all insulins in the medication cart belong to specific residents and no multidose insulin pens or vials were stock medications used for multiple residents. The facility's [DATE] Insulin Administration policy documented in part .5. The nursing staff will have access to specific instructions . on all forms of insulin delivery system(s) prior to their use 8. Facility will follow the manufacturer guidelines for stability of insulins and pens. For storage and use . the vial or pen should be dated when it is opened .Stability of Common Insulins in Vials and Pens . Opened at Room or Refrigerator Temperature (days): Novolog FlexPen 28 days, Levmir FlexPen 42 days, Basaglar 28 days, Humalog 28 days, Lantus 28 days . FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 145890 If continuation sheet Page 2 of 2

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

3 citations recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0761GeneralS&S Epotential for harm

    F761 - Labeling of Drugs and Biologicals

    Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs.

  • 0353GeneralS&S Epotential for harm

    Inspect, test, and maintain automatic sprinkler systems.

  • 0920GeneralS&S Epotential for harm

    F920 - Dining and Resident Activities

    Ensure proper usage of power strips and extension cords.

FAQ · About this visit

Common questions about this visit

What happened during the January 6, 2023 survey of ELDORADO REHAB & HEALTHCARE?

This was a inspection survey of ELDORADO REHAB & HEALTHCARE on January 6, 2023. The surveyor cited 3 deficiencies, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at ELDORADO REHAB & HEALTHCARE on January 6, 2023?

Yes, 3 deficiencies were cited, each with a CMS Scope and Severity grade. The first was: "Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional princip..."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

SourceView on CMS Care Compare

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.